C O M M U N I C A T I O N S
Scheme 5. Solid-Supported Phosphine Oxide: A Cleaner
Scheme 4. Coupling of 3-Nitrobenzene Sulfonic Acid with Amines
Alternative
Table 2. Amine Diversity in Sulfonamide Synthesis
providing that the resin is washed thoroughly after each cycle, no
activation of the phosphine oxide is required. This observation
represents a major advance in reaction efficiency since a single
batch of phosphine oxide resin can be used to generate a diverse
range of sulfonamides.
We have also established that, if required, the resin may be pre-
treated with triflic anhydride and then isolated by filtration and
stored under vacuum prior to use. This modification allows excess
triflic anhydride to be removed prior to the coupling reaction and
is particularly noteworthy if the resin is to be utilized in a parallel
fashion.
In conclusion, we have described a new synthesis of sulfonamides
and activated sulfonate esters from the sulfonic acid salt using the
activating agent triphenylphosphine ditriflate. The reaction has been
shown to display good functional group tolerance and is high
yielding. We have also demonstrated that triphenylphosphine oxide,
which can be troublesome to remove at the end of the reaction,
may be replaced by a solid-supported variant from which the
reaction products may be removed by washing. In summary, we
believe that this functional group transformation may obviate the
requirement to generate and use sulfonyl chlorides for the synthesis
of sulfonamides and activated sulfonate esters.
triethylamine salts of sulfonic acids are often suitable substrates
for this reaction since they are easily prepared from the parent acid
and are not particularly hygroscopic and usually soluble in organic
solvents. They are also easily purified by recrystallization (though
this is often not required). In cases where solubility of these salts
is particularly poor, the tetrabutylammonium salt may be employed
without significant decrease in yield or reaction efficiency.
Greatly encouraged by our initial studies, we wished to dem-
onstrate the generality of the approach to the synthesis of a diverse
range of sulfonamides. We chose, in this case to examine the
reaction of 3-nitrobenzene sulfonic acid pyridine salt with a number
of common amines (Scheme 4). The results are outlined in Table
2. Gratifyingly, it was observed that the reaction is not limited to
simple amines but enjoys success with primary, secondary, and
amino acid derivatives. Even electron-deficient anilines (entry 3,
Table 2) are applicable in the reaction.
It became clear to us that a phosphine oxide that could be more
easily removed from the reaction medium after the coupling had
taken place would greatly simplify our novel coupling protocol and
may enable us to eliminate chromatography entirely from the
procedure. We therefore obtained the commercially available
polystyrene-supported phosphine oxide A. To our delight, when
we substituted triphenylphosphine oxide for this analogous sup-
ported phosphine oxide, comparable yields of coupled product were
obtained (Scheme 5).13 In addition to this, purification could be
achieved without the use of column chromatography, simply by
filtering off the resin and then washing the filtrate with water to
remove any remaining salts. We were also pleased to observe that
the resin is recyclable and can be employed in another coupling
reaction. No loss in efficiency was observed after 5 cycles, and
Acknowledgment. We thank the EPSRC and GlaxoSmithKline
for generous financial support of this work. We also thank the
Association for International Cancer Research, BBSRC, and As-
traZeneca for the support of our program. We also gratefully
acknowledge the EPSRC Mass Spectroscopy Service at Swansea.
Supporting Information Available: Characterization data for the
sulfonate esters and the functionalized sulfonamides. This material is
References
(1) Navia, M. A. Science 2000, 288, 2132.
(2) Mohamed, S. K. Afinidad 2000, 57, 451.
(3) (a) For a review, see: Hansch, C.; Sammes, P. G.; Taylor, J. B.
ComprehensiVe Medicinal Chemistry; Pergamon Press: Oxford, 1990; Vol.
2, Chapter 7.1. (b) For recent biological applications, see: Hanson, P.
R.; Probst, D. A.; Robinson, R. E.; Yau, M. Tetrahedron Lett. 1999, 40,
476.
(4) McKerrow, J. H.; James, M. N. G. In PerspectiVes in Drug DiscoVery
and Design; Anderson, P. S., Kenyon, G. L., Marshall, G. R., Eds.;
ESCOM Science Publishers: Leiden, 1996; Vol. 6, pp 1-120.
(5) Roush, W. R.; Gwaltney, S. L., II; Cheng, J.; Scheidt,; McKerrow, J. H.;
Hansell, E. J. Am. Chem. Soc. 1998, 120, 10994.
(6) (a) Caddick, S.; Wilden, J. D.; Wadman, S. J.; Bush, H. D.; Judd, D. B.
Org. Lett. 2002, 4, 2549. (b) See also: Caddick, S.; Hamza, D.; Wadman,
S. J.; Wilden, J. D. Org. Lett. 2002, 4, 1775.
(7) For alternative routes to sulfonamides via sulfamoylation of aromatics,
see: Frost, C. G.; Hartley, J. P.; Griffin, D. Synlett 2002, 1928.
(8) Najera, C. Synlett 2002, 9, 1388.
(9) Hendrickson, J. B.; Scwartzman, S. M. Tetrahedron Lett. 1975, 16, 277.
(10) Aaberg, A.; Gramstad, T.; Husebye, S. Tetrahedron Lett. 1979, 20, 2263.
(11) Suter, C. M.; Evans, P. B.; Kiefer, J. M. J. Am. Chem. Soc. 1938, 60,
538.
(12) Smith, K.; Hou, D. J. Org. Chem. 1996, 61, 1530.
(13) (a) For other solid-phase approaches to sulfonamides, see: Maclean, D.;
Hale, R.; Chen, M. Y. Org. Lett. 2001, 3, 2977. (b) Raju, B.; Kogan, T.
P. Tetrahedron Lett. 1997, 38, 3373.
JA0397658
9
J. AM. CHEM. SOC. VOL. 126, NO. 4, 2004 1025